

Get the latest on the Amoxapine shortage in 2026. Learn what's causing it, how much it costs, and how to find Amoxapine in stock near you.
If you've been struggling to fill your Amoxapine prescription, you're dealing with a real problem. The shortage that started in mid-2024 has continued into 2026, leaving many patients scrambling to find their medication. In this update, we'll break down what's happening, why it's happening, and exactly what you can do about it.
Yes. As of early 2026, Amoxapine remains in a supply-limited status. The American Society of Health-System Pharmacists (ASHP) first reported the shortage in August 2024, noting that Teva Pharmaceuticals — the only US manufacturer of generic Amoxapine tablets — had limited supply of the 50 mg strength. While some strengths have become intermittently available, the situation has not been fully resolved.
The FDA's drug shortage database continues to list Amoxapine, and patients across the country report difficulty finding it at their local pharmacies.
The Amoxapine shortage is driven by a combination of factors:
The brand-name version of Amoxapine, Asendin, was discontinued in the United States years ago. Today, Teva Pharmaceuticals is the only company manufacturing generic Amoxapine tablets in the US market. When one company controls the entire supply, any disruption can cascade into a nationwide shortage.
Amoxapine is an older, less commonly prescribed tricyclic antidepressant. Compared to popular medications like Sertraline or Escitalopram, the market for Amoxapine is small. This makes it less profitable to produce and less likely to attract additional manufacturers.
The pharmaceutical supply chain has been under strain for years. Raw material sourcing, manufacturing capacity, and distribution issues all play a role. Older generic drugs with thin profit margins are disproportionately affected.
For a deeper dive into these causes, read our article on why Amoxapine is so hard to find.
Even when you can find Amoxapine, the cost can vary significantly:
During shortages, some pharmacies may charge higher prices due to limited supply. Always compare prices and check for coupons before you pay. Our guide on how to save money on Amoxapine has detailed pricing strategies.
Unfortunately, no new manufacturers have entered the US Amoxapine market as of early 2026. However, there are some developments worth noting:
Here are the most effective strategies for locating Amoxapine right now:
Medfinder lets you search for pharmacies near you that currently have Amoxapine available. It's free, fast, and covers both chain and independent pharmacies.
Independent pharmacies often have access to different wholesalers than large chains. They may have stock when CVS and Walgreens don't.
Mail-order pharmacies sometimes have larger inventories and can ship medications to you directly. Check with your insurance plan to see if mail-order is covered.
If a pharmacy has some Amoxapine but not enough for your full prescription, ask about a partial fill. You can get what's available now and pick up the rest when more stock arrives.
For more detailed strategies, see our full guide on how to find Amoxapine in stock near you.
If you're down to your last few pills and can't find Amoxapine:
The Amoxapine shortage is frustrating, but you have more options than you might think. Stay proactive, use the tools available to you, and keep your doctor informed about any challenges you're facing. Your mental health matters, and there are paths forward even when your usual medication is hard to find.
For more information about this medication, check out our complete guide on what is Amoxapine or learn about Amoxapine side effects.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.